Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia

Clinical trial NCT07513038 · RECRUITING

Trial details

NCT number: NCT07513038
Sponsor: Boston Children's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Biliary Atresia

Start date: 2024-08-01
Primary completion: 2026-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.